Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: Novel perspectives based on review of the literature

Oncotarget

Volumn 8, Issue 3, 2017, Pages 5498-5507

  Wang, Mao Jie ^a   Xu, Yong Yue ^a   Huang, Run Yue ^a,b,c   Chen, Xiu Min ^a   Chen, Hai Ming ^a   Han, Ling ^a   Yan, Yu Hong ^a   Lu, Chuan Jian ^a,c  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Pharmacology Research Laboratory of Traditional Chinese Medicine   (China)

Author keywords

Cell differentiation; Cell proliferation; Imbalanced miRNAs axis; Keratinocytes; Psoriasis

Indexed keywords

HSA MICRORNA 99A; MICRORNA; MICRORNA 125B; MICRORNA 203; MICRORNA 31; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; KERATINOCYTE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PSORIASIS; UPREGULATION; GENETICS;

HUMANS; MICRORNAS; PSORIASIS;

EID: 85011995322     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12534     Document Type: Article

References (46)

1. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, Scheynius A, Stahle M and Pivarcsi A. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PloS one. 2007; 2:e610.
2. Zhao YK, Zhang YQ, Wang F, Wu HH, Luo ZY, Luo DQ and Chen WN. Developing Shingles-Induced Koebner Phenomenon in a Patient With Psoriasis: A Case Report. Medicine. 2015; 94:e1009.
3. Pivarcsi A, Stahle M and Sonkoly E. Genetic polymorphisms altering microRNA activity in psoriasis-a key to solve the puzzle of missing heritability? Experimental dermatology. 2014; 23:620-624.
4. Jinnin M. [microRNA in autoimmune disorders]. [Article in Japanese]. Nihon Rinsho Men'eki Gakkai kaishi. 2011; 34:439-446.
5. Huang RY, Li L, Wang MJ, Chen XM, Huang QC and Lu CJ. An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature. Medicine. 2015; 94:e2030.
6. Sonkoly E, Stahle M and Pivarcsi A. MicroRNAs: novel regulators in skin inflammation. Clinical and experimental dermatology. 2008; 33:312-315.
7. Zibert JR, Lovendorf MB, Litman T, Olsen J, Kaczkowski B and Skov L. MicroRNAs and potential target interactions in psoriasis. Journal of dermatological science. 2010; 58:177-185.
8. Joyce CE, Zhou X, Xia J, Ryan C, Thrash B, Menter A, Zhang W and Bowcock AM. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Human molecular genetics. 2011; 20:4025-4040.
9. Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, Gradus B, Pavlotsky F, Barshack I, Polak-Charcon S, Orenstein A, Hornstein E, Sidi Y and Avni D. MiRNA expression in psoriatic skin: reciprocal regulation of hsamiR-99a and IGF-1R. PloS one. 2011; 6:e20916.
10. Xu N, Meisgen F, Butler LM, Han G, Wang XJ, Soderberg-Naucler C, Stahle M, Pivarcsi A and Sonkoly E. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. Journal of immunology. 2013; 190:678-688.
11. Peng H, Kaplan N, Hamanaka RB, Katsnelson J, Blatt H, Yang W, Hao L, Bryar PJ, Johnson RS, Getsios S, Chandel NS and Lavker RM. microRNA-31/factor-inhibiting hypoxia-inducible factor 1 nexus regulates keratinocyte differentiation. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109:14030-14034.
12. Yan S, Xu Z, Lou F, Zhang L, Ke F, Bai J, Liu Z, Liu J, Wang H, Zhu H, Sun Y, Cai W, Gao Y, Su B, Li Q, Yang X, et al. NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nature communications. 2015; 6:7652.
13. Huang J, Teng L, Liu T, Li L, Chen D, Li F, Xu LG, Zhai Z and Shu HB. Identification of a novel serine/threonine kinase that inhibits TNF-induced NF-kappaB activation and p53-induced transcription. Biochemical and biophysical research communications. 2003; 309:774-778.
14. Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, Olokpa E, Zariff A, Gunaratne PH, Matzuk MM and Anderson ML. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer research. 2010; 70:1906-1915.
15. Xu N, Brodin P, Wei T, Meisgen F, Eidsmo L, Nagy N, Kemeny L, Stahle M, Sonkoly E and Pivarcsi A. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. The Journal of investigative dermatology. 2011; 131:1521-1529.
16. Li D, Li X, Wang A, Meisgen F, Pivarcsi A, Sonkoly E, Stahle M and Landen NX. MicroRNA-31 Promotes Skin Wound Healing by Enhancing Keratinocyte Proliferation and Migration. The Journal of investigative dermatology. 2015; 135:1676-1685.
17. Djalilian AR, Namavari A, Ito A, Balali S, Afshar A, Lavker RM and Yue BY. Down-regulation of Notch signaling during corneal epithelial proliferation. Molecular vision. 2008; 14:1041-1049.
18. Watt FM, Estrach S and Ambler CA. Epidermal Notch signalling: differentiation, cancer and adhesion. Current opinion in cell biology. 2008; 20:171-179.
19. Sun Y, Li XQ, Sahbaie P, Shi XY, Li WW, Liang DY and Clark JD. miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression. Anesthesiology. 2012; 117:626-638.
20. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, Melino G and Candi E. miR-203 represses 'stemness' by repressing DeltaNp63. Cell death and differentiation. 2008; 15:1187-1195.
21. Kubo M, Hanada T and Yoshimura A. Suppressors of cytokine signaling and immunity. Nature immunology. 2003; 4:1169-1176.
22. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ and DiGiovanni J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nature medicine. 2005; 11:43-49.
23. Lowes MA, Bowcock AM and Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007; 445:866-873.
24. Jackson SJ, Zhang Z, Feng D, Flagg M, O'Loughlin E, Wang D, Stokes N, Fuchs E and Yi R. Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development. 2013; 140:1882-1891.
25. Barton CE, Johnson KN, Mays DM, Boehnke K, Shyr Y, Boukamp P and Pietenpol JA. Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation. Cell death & disease. 2010; 1:e74.
26. Borrelli S, Candi E, Hu B, Dolfini D, Ravo M, Grober OM, Weisz A, Dotto GP, Melino G, Vigano MA and Mantovani R. The p63 target HBP1 is required for skin differentiation and stratification. Cell death and differentiation. 2010; 17:1896-1907.
27. Candi E, Terrinoni A, Rufini A, Chikh A, Lena AM, Suzuki Y, Sayan BS, Knight RA and Melino G. p63 is upstream of IKK alpha in epidermal development. Journal of cell science. 2006; 119:4617-4622.
28. Masse I, Barbollat-Boutrand L, Molina M, Berthier-Vergnes O, Joly-Tonetti N, Martin MT, Caron de Fromentel C, Kanitakis J and Lamartine J. Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes. Cell death & disease. 2012; 3:e318.
29. Okuyama R, Tagami H and Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. Journal of dermatological science. 2008; 49:187-194.
30. Senoo M, Pinto F, Crum CP and McKeon F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell. 2007; 129:523-536.
31. Straub WE, Weber TA, Schafer B, Candi E, Durst F, Ou HD, Rajalingam K, Melino G and Dotsch V. The C-terminus of p63 contains multiple regulatory elements with different functions. Cell death & disease. 2010; 1:e5.
32. Talos F, Wolff S, Beyer U, Dobbelstein M and Moll UM. Brdm2-an aberrant hypomorphic p63 allele. Cell death and differentiation. 2010; 17:184-186.
33. Yi R, Poy MN, Stoffel M and Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature. 2008; 452:225-229.
34. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y and Dahiya R. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clinical cancer research. 2011; 17:5287-5298.
35. Viticchie G, Lena AM, Latina A, Formosa A, Gregersen LH, Lund AH, Bernardini S, Mauriello A, Miano R, Spagnoli LG, Knight RA, Candi E and Melino G. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell cycle. 2011; 10:1121-1131.
36. Rensen WM, Mangiacasale R, Ciciarello M and Lavia P. The GTPase Ran: regulation of cell life and potential roles in cell transformation. Frontiers in bioscience. 2008; 13:4097-4121.
37. Yudin D and Fainzilber M. Ran on tracks-cytoplasmic roles for a nuclear regulator. Journal of cell science. 2009; 122:587-593.
38. Jeon H, Zheng LT, Lee S, Lee WH, Park N, Park JY, Heo WD, Lee MS and Suk K. Comparative analysis of the role of small G proteins in cell migration and cell death: cytoprotective and promigratory effects of RalA. Experimental cell research. 2011; 317:2007-2018.
39. Lafuente EM, van Puijenbroek AA, Krause M, Carman CV, Freeman GJ, Berezovskaya A, Constantine E, Springer TA, Gertler FB and Boussiotis VA. RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Developmental cell. 2004; 7:585-595.
40. Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, Evans C, Jensen RV, Moskaluk CA and Dutta A. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer research. 2011; 71:1313-1324.
41. Baserga R, Peruzzi F and Reiss K. The IGF-1 receptor in cancer biology. International journal of cancer. 2003; 107:873-877.
42. Dotto GP. Notch tumor suppressor function. Oncogene. 2008; 27:5115-5123.
43. Bracke S, Desmet E, Guerrero-Aspizua S, Tjabringa SG, Schalkwijk J, Van Gele M, Carretero M and Lambert J. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model. Archives of dermatological research. 2013; 305:501-512.
44. Primo MN, Bak RO, Schibler B and Mikkelsen JG. Regulation of pro-inflammatory cytokines TNFalpha and IL24 by microRNA-203 in primary keratinocytes. Cytokine. 2012; 60:741-748.
45. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. Journal of immunology. 2007; 179:5082-5089.
46. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E and Soumelis V. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nature immunology. 2008; 9:650-657.